Here Comes The Sunshine Act - This Time, In Europe

By D. Jeffrey Campbell and Brian P. Sharkey

Law360, New York (June 25, 2013, 1:12 PM ET) -- When it comes to mandating transparency in the relationships between life sciences companies and health care professionals, it appears that Europe will not be outdone by the United States. Although compliance professionals at global pharmaceutical and medical device companies lately have been fixated on the recently released final regulations implementing the Sunshine Act provisions of the Patient Protection and Affordable Care Act, a U.S.-centric approach will fail to address the growing demands of European transparency regulations.